David Valcárcel-Ferreiras

20PUBLICATIONS
136CO-AUTHORS
Oral medicine and pathologyMedical mycologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene mapping
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 11, 2026
Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 09, 2026
Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Sara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà

Pageof 4

Frequent Collaborators

5 joint publications

Francesc Solé

4 joint publications

Francesc Bosch

4 joint publications

María Díez-Campelo

4 joint publications

Valeria Santini